SPP1 polymorphisms associated with HBV clearance and HCC occurrence
Author(s) -
H. D. Shin,
B. L. Park,
H. S. Cheong,
JungHwan Yoon,
Yoon Jun Kim,
H.-S. Lee
Publication year - 2007
Publication title -
international journal of epidemiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.406
H-Index - 208
eISSN - 1464-3685
pISSN - 0300-5771
DOI - 10.1093/ije/dym093
Subject(s) - hepatocellular carcinoma , medicine , hepatitis b virus , genotype , taqman , population , hepatitis b , gastroenterology , haplotype , immunology , gene , biology , real time polymerase chain reaction , virus , genetics , environmental health
Secreted phosphoprotein-1 (SPP1) is a secreted arginine-glycine-aspartate (RGD)-containing phosphoprotein. SPP1 is overexpressed in metastatic hepatocellular carcinoma (HCC), and therefore could act as both a diagnostic marker and a potential therapeutic target for metastatic HCC. We investigated the genetic polymorphisms in SPP1 to determine whether it is a potential candidate gene for a host genetic study of hepatitis B virus (HBV) clearance and HCC occurrence.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom